It is not medical advice and should not be used as a substitute for professional evaluation, diagnosis, or treatment from a qualified healthcare provider
Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
Never artificially heat tirzepatide with a microwave or hot water, as this damages the peptide structure
With regular check-ins and adjustments, we ensure you stay on track, overcome plateaus, and build the healthy habits needed for long-term success
The studys limitations include the small sample size, short duration, lack of assessor blinding, and absence of detailed monitoring of diet and physical activity, all of which may affect interpretation